Risk Factors for Symptomatic Mitochondrial Toxicity in HIV/Hepatitis C Virus-Coinfected Patients During Interferon Plus Ribavirin-Based Therapy-Reference-Cited by-同舟云学术

Risk Factors for Symptomatic Mitochondrial Toxicity in HIV/Hepatitis C Virus-Coinfected Patients During Interferon Plus Ribavirin-Based Therapy

Published:2005-09-01 Issue:1 Volume:40 Page:47-52
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Bani-Sadr Firouzé,Carrat Fabrice,Pol Stanislas,Hor Ravy,Rosenthal Eric,Goujard Cécile,Morand Patrice,Lunel-Fabiani Françoise,Salmon-Ceron Dominique,Piroth Lionel,Pialoux Gilles,Bentata Michèle,Cacoub Patrice,Perronne Christian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference21 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.;Manns;Lancet,2001

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.;Fried;N Engl J Med,2002

3. Pegylated interferon alfa-2b versus standard interferon alfa-2b, plus ribavirin for chronic hepatitis C in HIV-infected patients: randomized controlled trial.;Carrat;JAMA,2004

4. Impaired mitochondrial function in microvesicular steatosis: effects of drugs, ethanol, hormones and cytokines.;Fromenty;J Hepatol,1997

5. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection.;Lafeuillade;Lancet,2001

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucoadhesive Drug Delivery System in Chronic Respiratory Diseases;Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases;2022

2. Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview;Pharmacology Research & Perspectives;2021-01-09

3. HIV and the Liver;Zakim and Boyer's Hepatology;2018

4. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH);Journal of Viral Hepatitis;2017-11-20

5. Synthesis and antiviral evaluation of novel N-6 substituted adenosine analogues;Tetrahedron Letters;2017-01